Listar por tema "glucose 6 phosphate dehydrogenase deficiency"

Mostrando ítems 1-2 de 2

Prospects for malaria elimination in non-Amazonian regions of Latin America

Herrera, S.; Quiñones, M.L.; Quintero, J.P.; Corredor, V.; Fuller, D.O.; Mateus, J.C.; Calzada, J.E.; Gutierrez, J.B.; Llanos Cuentas, Elmer Alejandro; Soto, E.; Menendez, C.; Wu, Y.; Alonso, P.; Carrasquilla, G.; Galinski, M.; Beier, J.C.; Arévalo-Herrera, M. (Elsevier, 2012)

Latin America contributes 1-1.2 million clinical malaria cases to the global malaria burden of about 300 million per year. In 21 malaria endemic countries, the population at risk in this region represents less than 10% of ...
Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria

Llanos Cuentas, Elmer Alejandro; Lacerda, M.V.G.; Hien, T.T.; Vélez, I.D.; Namaik-Larp, C.; Chu, C.S.; Villegas, M.F.; Val, F.; Monteiro, W.M.; Brito, M.A.M.; Costa, M.R.F.; Chuquiyauri, R.; Casapía, M.; Nguyen, C.H.; Aruachan, S.; Papwijitsil, R.; Nosten, F.H.; Bancone, G.; Angus, B.; Duparc, S.; Craig, G.; Rousell, V.M.; Jones, S.W.; Hardaker, E.; Clover, D.D.; Kendall, L.; Mohamed, K.; Koh, G.C.K.W.; Wilches, V.M.; Breton, J.J.; Green, J.A. (Massachusetts Medical Society, 2019)

BACKGROUND: Tafenoquine, a single-dose therapy for Plasmodium vivax malaria, has been associated with relapse prevention through the clearance of P. vivax parasitemia and hypnozoites, termed "radical cure." METHODS: We ...

Buscar en el Repositorio